Corrigendum to "Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response" [Eur J Med Chem. 192 2020 112158]
Eur J Med Chem. 2020 Jun 15:196:112329.
doi: 10.1016/j.ejmech.2020.112329.
Epub 2020 Apr 20.
1 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taiwan.
2 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taiwan; TMU Biomedical Commercialization Center, Taipei Medical University, Taiwan; Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
3 TMU Biomedical Commercialization Center, Taipei Medical University, Taiwan.
4 Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address: brianchc@tmu.edu.tw.
5 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taiwan; TMU Biomedical Commercialization Center, Taipei Medical University, Taiwan; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan. Electronic address: jpl@tmu.edu.tw.